Department of Urology, Seoul National University Bundang Hospital, 173-82, Gumi-Ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, South Korea.
Data Science Team, Hanmi Pharm. Co., Ltd, Seoul, South Korea.
World J Urol. 2022 Nov;40(11):2781-2787. doi: 10.1007/s00345-022-04165-2. Epub 2022 Oct 6.
Inflammation is thought to affect the development of prostate cancer (PCa). By retrospectively investigating the database of the National Health Insurance Service, this study attempted to perform a relevant analysis of patients with prostatitis and PCa.
Participants were aged ≥ 50 years. Patients diagnosed with prostatitis between 2010 and 2013 and matched controls were followed up until 2019. We selected controls with matched propensity scores for age, diabetes, hypertension, and the Charlson comorbidity index. Multivariate Cox regression analysis was conducted to determine the hazard ratio (HR) and 95% confidence interval (CI) of the association between prostatitis and PCa. The HR for PCa according to the presence of prostatitis was classified as acute, chronic, or other prostatitis.
A total of 746,176 patients from each group were analyzed. The incidence of PCa was significantly higher in the group with prostatitis (1.8% vs 0.6%, p < 0.001). The HR for PCa was significantly higher in patients with prostatitis (HR 2.99; 95% CI 2.89-3.09, p < 0.001). The HR for PCa was significantly higher in acute prostatitis than in chronic prostatitis (3.82; 95% CI 3.58-4.08; p < 0.001; HR 2.77; 95% CI 2.67-2.87, p < 0.001). The incidence of all-cause death in patients diagnosed PCa was significantly lower in prostatitis group (HR 0.58, 95% CI 0.53-0.63, p < 0.001).
Prostatitis is associated with an increased incidence of PCa. Acute prostatitis is associated with higher risk of PCa than chronic prostatitis. Clinicians should inform patients with prostatitis that they may have an increased risk of diagnosing PCa, and follow-up is needed.
炎症被认为会影响前列腺癌(PCa)的发展。本研究通过回顾性调查国家健康保险服务数据库,试图对前列腺炎和 PCa 患者进行相关分析。
参与者年龄≥50 岁。2010 年至 2013 年间被诊断为前列腺炎的患者与匹配对照者进行随访,直至 2019 年。我们为年龄、糖尿病、高血压和 Charlson 合并症指数匹配的对照者选择了匹配倾向评分。采用多变量 Cox 回归分析确定前列腺炎与 PCa 之间的危险比(HR)和 95%置信区间(CI)。根据前列腺炎的存在将 PCa 的 HR 分为急性、慢性或其他前列腺炎。
对每组的 746176 名患者进行了分析。前列腺炎组的 PCa 发生率明显更高(1.8% vs 0.6%,p<0.001)。前列腺炎患者的 PCa 发生 HR 明显更高(HR 2.99;95%CI 2.89-3.09,p<0.001)。急性前列腺炎患者的 PCa 发生 HR 明显高于慢性前列腺炎患者(3.82;95%CI 3.58-4.08;p<0.001;HR 2.77;95%CI 2.67-2.87,p<0.001)。确诊为 PCa 的患者全因死亡发生率在前列腺炎组明显较低(HR 0.58,95%CI 0.53-0.63,p<0.001)。
前列腺炎与 PCa 的发病率增加有关。急性前列腺炎与慢性前列腺炎相比,PCa 的风险更高。临床医生应告知患有前列腺炎的患者,他们可能有更高的诊断 PCa 的风险,需要进行随访。